Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS
Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke, Heankel Lyons, Elana Molotsky, Juliane S. Bombosch, Odilia Sianto, Jay P. Ross, Phuong Hoang, Luke Zhao, Cole Spencer, Charlotte J. Sumner, Michelle Monje, John W. Day, Aaron D. Gitler
Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke, Heankel Lyons, Elana Molotsky, Juliane S. Bombosch, Odilia Sianto, Jay P. Ross, Phuong Hoang, Luke Zhao, Cole Spencer, Charlotte J. Sumner, Michelle Monje, John W. Day, Aaron D. Gitler
View: Text | PDF
Research Article Genetics Neuroscience

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS

  • Text
  • PDF
Abstract

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by mutations in the survival motor neuron 1 (SMN1) gene leading to decreased SMN protein levels and motor neuron dysfunction. SMN-restoring therapies offer clinical benefit, but the downstream molecular consequences of SMN reduction remain incompletely understood. SMN deficiency resulted in downregulation of kinesin heavy chain isoform 5A (KIF5A) in human neurons and in a mouse model of SMA. SMN associated with KIF5A mRNA and contributed to its stability. Reduced SMN levels impaired axon regeneration, which was rescued by KIF5A overexpression. Because KIF5A has also been connected to ALS, these findings provide evidence of a molecular link between SMA and ALS pathophysiology, highlighting KIF5A as an SMN-regulated factor. Our findings suggest that SMN-independent interventions targeting KIF5A could represent a complementary therapeutic approach for SMA and other motor neuron diseases.

Authors

Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke, Heankel Lyons, Elana Molotsky, Juliane S. Bombosch, Odilia Sianto, Jay P. Ross, Phuong Hoang, Luke Zhao, Cole Spencer, Charlotte J. Sumner, Michelle Monje, John W. Day, Aaron D. Gitler

×

Figure 1

SMN deficiency downregulates KIF5A expression.

Options: View larger image (or click on image) Download as PowerPoint
SMN deficiency downregulates KIF5A expression.
(A) Two types of human ne...
(A) Two types of human neurons were generated and analyzed. Td-Tomato+ motor neurons (iMNs) were derived from human iPSCs by small molecule treatment and purified using fluorescence-activated cell sorting (FACS) under the control of the HB9 promoter. In parallel, i3Neurons (i3Ns) were produced by doxycycline-induced NGN2 expression from isogenic, integrated human H1 ESCs (Supplemental Table 1). Both iMNs and i3Ns were subsequently transduced with lentivirus carrying shRNA targeting SMN1/2 (SMN-KD), followed by RNA-seq. (B and C) Volcano plots showing differentially expressed genes (DEGs) in iMNs (B) and i3Ns (C) following SMN-KD. Each plot displays log2 fold change (x axis) versus negative log10 adjusted P-value (y axis). Genes significantly upregulated (red dots) or downregulated (blue dots) are defined by adjusted P < 0.01 and |log2 fold change| > 1. (D and E) Venn diagrams integrating RNA-seq datasets from iMNs (red), i3Ns (blue), and laser-microdissected motor neurons from SMA model mice (yellow) (37). Downregulated DEGs (D) and upregulated DEGs (E) were defined by adjusted P < 0.01 and |log2 fold change| > 1. Gene lists are provided in Supplemental Table 2. KIF5A was identified as a commonly downregulated gene. (F–I) Western blot analysis of i3N lysates following SMN-KD (F) and of primary mouse cortical neurons treated with siRNAs targeting Smn (H), confirming reduced SMN and KIF5A protein levels. Quantification of SMN and KIF5A protein levels relative to scrambled controls (SCR or Scr) is shown in G and I. Data represent 3 independent experiments. Statistical analysis was performed using an unpaired 2-tailed t test with Welch’s correction.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts